ADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

adcetris brentuximab vedotin (rch) 50 mg powder for injection vial

takeda pharmaceuticals australia pty ltd - brentuximab vedotin, quantity: 50 mg - injection, powder for - excipient ingredients: citric acid monohydrate; trehalose dihydrate; sodium citrate dihydrate; polysorbate 80 - hodgkin lymphoma,treatment of patients with previously untreated cd30+ stage iii or stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine, and dacarbazine (avd).,treatment of adult patients with cd30+ hl at higher risk of relapse or progression following asct.,treatment of adult patients with relapsed or refractory cd30+ hl:,1. following autologous stem cell transplant (asct) or,2. following at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option.,peripheral t-cell lymphoma,treatment of adult patients with previously untreated cd30+ peripheral t-cell lymphoma (ptcl) in combination with cyclophosphamide, doxorubicin, and prednisone (chp).,treatment of adult patients with relapsed or refractory systemic anaplastic large cell lymphoma (salcl).,cutaneous t cell lymphoma,treatment of adult patients with cd30+ cutaneous t-cell lymphoma (ctcl) after at least 1 prior systemic therapy.

ZOLINZA vorinostat 100 mg capsule bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

zolinza vorinostat 100 mg capsule bottle

merck sharp & dohme (australia) pty ltd - vorinostat, quantity: 100 mg - capsule - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; titanium dioxide; sorbitan monolaurate; potable water; gelatin; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - zolinza is indicated for the treatment of cutaneous manifestations in patients with cutaneous t-cell lymphoma (ctcl) who have progressive, persistent or recurrent disease subsequent to prior systemic therapies.

ADCETRIS  50 MG Iżrael - Ingliż - Ministry of Health

adcetris 50 mg

takeda israel ltd - brentuximab vedotin - powder for concentrate for solution for infusion - brentuximab vedotin 50 mg/vial - brentuximab vedotin - adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl): 1. following autologous stem cell transplant (asct) or 2. following at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. adcetris is indicated for the treatment of adult patients with relapsed or refractory systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following asct. adcetris is indicated for the treatment of adult patients with cd30+ cutaneous t-cell lymphoma (ctcl) after at least 1 prior systemic therapy . adcetris is indicated for the treatment of adult patients with previously untreated stage iii or iv classical hodgkin lymphoma (chl), in combination with doxorubicin, vinblastine, and dacarbazine.adcetris is indicated for the treatment of adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl) or other cd30-expressing peripheral t-cell lymphomas (ptcl), including angioimmunoblastic t-cell lymphoma and ptcl not otherwise specified, in combination with cyclophosphamide, doxorubicin, and prednisone.

EVC HAND SANITIZER- isopropyl alcohol solution Stati Uniti - Ingliż - NLM (National Library of Medicine)

evc hand sanitizer- isopropyl alcohol solution

ctc enterprise ventures corporation - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antiseptic health care personnel hand rub to help reduce bacteria that potentially can cause disease.

LEDAGA chlormethine (as hydrochloride) 160 microgram/g topical gel tube Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ledaga chlormethine (as hydrochloride) 160 microgram/g topical gel tube

juniper biologics pty ltd - chlormethine hydrochloride, quantity: 0.2 mg/g (equivalent: chlormethine, qty 0.16 mg/g) - gel - excipient ingredients: butylated hydroxytoluene; disodium edetate; diethylene glycol monoethyl ether; isopropyl alcohol; hyprolose; lactic acid; propylene glycol; glycerol; menthol; sodium chloride - ledaga is indicated for the topical treatment of mycosis fungoides-type cutaneous t-cell lymphoma (mf-type ctcl) in adult patients.

Daesung Maref Circulating-Fluid Thermal Compression Therapy System Control Unit CTC-7 Singapor - Ingliż - HSA (Health Sciences Authority)

daesung maref circulating-fluid thermal compression therapy system control unit ctc-7

ids medical systems (singapore) pte ltd - general hospital - the purpose of this system is to treat post- operative injuries and acute injuries to reduce swelling, edema and pain. it is to treat symptoms requiring medically or surgically local thermal therapy (cold, heat, rct) after post-traumatic or post-operative.